Abstract Aim The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure”
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …

Medical soft robotics constitutes a rapidly developing field in the treatment of cardiovascular
diseases, with a promising future for millions of patients suffering from heart failure …

ABSTRACT Aim The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure”
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …

Purpose Device-induced blood damage contributes the hemolysis, thrombosis and bleeding
complications in patients supported with ventricular assist device (VAD). This study aims to …

Background The objectives of this study was to investigate if concomitant tricuspid valve
repair in patients undergoing continuous flow left ventricular assist device (LVAD) …

Introduction: The miniaturization of blood pumps has become a trend due to the advantage
of easier transplantation, especially for pediatric patients. In small-scale pumps, it is much …

The use of left ventricular assist devices (LVADs) for advanced heart failure is becoming
increasingly common. However, optimal timing and patient selection remain controversial …

Background and Objectives: The understanding of high body mass index (BMI) and
outcomes after Left Ventricular Assist Device (LVAD) implantation continues to evolve and …

Background Infections are the most common complication in recipients of durable left
ventricular assist devices (LVAD) and are associated with increased morbidity, mortality, and …

Continuous‐flow left ventricular assist devices (LVADs) have gained tremendous
acceptance for the treatment of end‐stage heart failure patients. Among different versions …